Vaxdyn Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • Seed
  • Investors
  • 7

Vaxdyn General Information


Developer of immunotherapies and vaccines designed to prevent infectious diseases. The company's vaccines use antigens, immunomodulators, nanoparticles and mAbs to fight bacterial infections, enabling doctors to decrease the impact of infections caused by drug-resistant pathogens on public health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Parque Ciudad del Conocimiento, Calle Miguel Manaute Humanes s/n
  • Edificio central, despacho 6
  • 41704 Dos Hermanas
  • Spain
+34 606 00 00 00

Vaxdyn Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaxdyn Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 08-Mar-2021 00.00 Completed Generating Revenue
3. Grant 07-Jul-2020 00.000 00.00 Completed Generating Revenue
2. Secondary Transaction - Private $1.2M Completed Startup
1. Seed Round 01-Jan-2016 $1.2M $1.2M Completed Startup
To view Vaxdyn’s complete valuation and funding history, request access »

Vaxdyn Executive Team (4)

Name Title Board Seat Contact Info
Juanjo Infante Ph.D Chief Executive Officer & President of the Board
Michael McConnell Ph.D Co-Founder and Chief Scientific Officer
Pilar Romero Ph.D Co-Founder & Advisor
You’re viewing 3 of 4 executive team members. Get the full list »

Vaxdyn Board Members (4)

Name Representing Role Since
Francisco Leon Ph.D Self Board Member 000 0000
Pilar Huerta Ph.D Self Board Member 000 0000
Ricardo Henriques Ph.D Bionova Capital Board Member 000 0000
Santiago Pla Arquimea Group Board Member 000 0000
To view Vaxdyn’s complete board members history, request access »

Vaxdyn Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vaxdyn Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arquimea Group Corporation Minority 000 0000 000000 0
Bionova Capital Venture Capital Minority 000 0000 000000 0
Botín Foundation Accelerator/Incubator Minority 000 0000 000000 0
Laboratorio Reig Jofré Corporation Minority 000 0000 000000 0
CARB-X University 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »